ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

IOM To Advise Army On Spending $210 Mil. Breast Cancer Money

January 8, 1993

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

New RFAs Released: Kaposi Sarcoma; Rare Tumors; Biochemical Epidemiology; Dietary Questionnaire; Role of Nicotine

August 20, 1982

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

March 7, 2008

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987